December 14, 2017 11:32 PM ET
Capital Markets
Company Overview of CRT Private Equity
Executive Profile
George W. Bickerstaff III | |
| Age | Total Calculated Compensation | This person is connected to 6 Board Members in 6 organization across 14 different industries.
See Board Relationships |
| 61 | --
|
Background
Mr. George W. Bickerstaff III serves as the Managing Director of M.M. Dillon & Co., LLC and CRT Private Equity. Mr. Bickerstaff joined M.M. Dillon & Co. in 2005 and is its Partner. He served as the Managing Director at CRT Capital Group LLC specializing in healthcare banking since 2005. Prior to joining CRT Capital Group, he served as Chief Financial Officer of Novartis Pharma AG located in Basel, Switzerland from October 2000 to May 2005. He served as Chief Financial
... Officer, Executive Vice President and Secretary of Workscape, Inc. from December 1999 to September 2000 and also served as its Principal Accounting Officer. Mr. Bickerstaff held various positions with Novartis International AG From July 1998 to December 1999, he served as Executive Vice President and Chief Financial Officer of Uniscribe Professional Services, Inc. From January 1998 to June 1998, Mr. Bickerstaff served as Executive Vice President and Chief Financial Officer of Intellisource Group, Inc. From July 1997 to December 1997, he served as Vice President of Finance of Cognizant Corporation. From January 1990 to June 1997, he served in various senior finance roles, including Chief Financial Officer of IMS Healthcare. He served as Chief Financial Officer of IMS Health Holdings, Inc. He serves as the Chairman at Cyclica Inc. He has been the Chairman of Cardax, Inc., since August 12, 2016. Prior to that, he held various finance, audit and engineering positions with the Dun & Bradstreet Corporation from 1985 to 1989 and General Electric Company from 1978 to 1985. Mr. Bickerstaff has over 35 years of experience in the financial services, healthcare and information technology industries and has been instrumental in establishing the strategic, operating and financial direction of numerous private and public companies. Mr. Bickerstaff has been an Independent Director of CareDx, Inc. since April 8, 2014 and Oracle Healthcare Acquisition Corp. since September 2005. He has been a Director of Inovio Pharmaceuticals, Inc. since March 21, 2017. He has been an Independent Director of Cardax, Inc. since June 16, 2014. He has been on the board of directors and board of trustees of more than a dozen international private and public companies and philanthropic organizations. He served as a Director of ARIAD Pharmaceuticals, Inc. from May 4, 2016 to February 16, 2017 and Viventia Bio Inc. since February 2015. He served as a Director of Novartis Pharma AG. He served as a Director of BMP Sunstone Corporation since April 28, 2008, Amazys Holding GmbH since May 10, 2005 and Vion Pharmaceuticals Inc. since June 9, 2005. He is a guest speaker on global finance at various international industry associations and graduate business schools, including Harvard Business School. He serves as a Trustee of the International Vaccine Institute, the International Centre for Missing and Exploited Children, The Center for Disease Dynamics, Economics & Policy and The Global Alliance For Vaccines and Immunization. Mr. Bickerstaff received a Bachelor of Science degree in Engineering and a Bachelor of Arts degree in business administration from Rutgers University in 1978.
Corporate Headquarters
262 Harbor Drive
Stamford, Connecticut 06902
United States
Phone: 203-569-6400
Fax: 203-569-6499
Board Members Memberships
Trustee Chairman 2005-Present Director 2014-Present Independent Director 2014-Present Chairman 2017-Present Director
Education
BA 1978 Rutgers, The State University of New Jersey BS Rutgers, The State University of New Jersey
Other Affiliations
|
Annual Compensation
There is no Annual Compensation data available.
Stocks Options
There is no Stock Options data available.
Total Compensation
There is no Total Compensation data available.
|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
here.
Stock Quotes
Market data is delayed at least 15 minutes.
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Sponsored Financial Commentaries
Sponsored Links
